Senior insider sale
RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$2.84M
660K shares
What this filing means
BORGESON BLAKE plans to sell 660K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $2.84M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/3/2026ACC: 0001959173-26-000567
Director
Since Apr 2021
660K
Shares to sell
$2.84M
Approx. market value
220K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Founders Shares
Compensation
9/1/2017
110KFounders Shares
Compensation
9/1/2016
110KTotal acquired220K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2017 | Founders Shares Compensation | 110K | — |
9/1/2016 | Founders Shares Compensation | 110K | — |
| Total | 220K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
220K
Market value
$959.2K
1/6/2026
—Completed
Units to sell
220K
Market value
$961.4K
12/2/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
220K
Market value
$924.0K
2/3/2026
Total
Units
660K
Value
$2.84M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/6/2026 | 220K | $959.2K | — | Completed |
12/2/2025 | 220K | $961.4K | — | Completed |
| Planned — Approximate Date | ||||
2/3/2026 | 220K | $924.0K | NASDAQ | Planned |
| Total | 660K | $2.84M | ||